| BW | Body Weight |
| CA | Closed Arms |
| CEN | Center |
| CON | Control Group |
| diCQA | dicaffeoylquinic acid |
| DTa | Decoction of T. absinthioides |
| DTa10 | Decoction 10% w/v of T. absinthioides Group |
| DTa5 | Decoction 5% w/v of T. absinthioides Group |
| EPM | Elevated Plus Maze |
| GLU | Basal Glucose |
| GTT | Glucose Tolerance Test |
| HDL-c | High-Density Lipoprotein Cholesterol |
| iAUC | Incremental Area Under Curve |
| MET12.5 | Metformin 12.5 mg/kg Group |
| MET25 | Metformin 25 mg/kg Group |
| NOL | Novel Object Location |
| OA | Open Arms |
| OFT | Open Field Test |
| RM-ANOVA | Repeated Measure ANOVA |
| SD | Standard Deviation |
| SDTa10 | Sucrose 10% w/v + Decoction 10% w/v of T. absinthioides Group |
| SDTa5 | Sucrose 10% w/v +Decoction 5% w/v of T. absinthioides Group |
| SMET12.5 | Sucrose 10% w/v + Metformin 12.5 mg/kg Group |
| SMET25 | Sucrose 10% w/v + Metformin 25 mg/kg Group |
| SUC | Sucrose 10% w/v Group |
| SUC-GR | sucrose-induced metabolic challenge condition |
| T1 | Trial 1 |
| T2 | Trial 2 |
| UHPLC-PDA-OT-MS/MS | Ultra-High Performance Liquid Chromatography-Photodiode Array Detector Orbitrap Mass Spectrometry |
| WAT-GR | normal conditions |